Editorial - Vigilância pós-comercialização – Monitoramento, tecnovigilância e farmacovigilância

Read full text
Authors: Flávia Tavares Silva Elias, Margarete Martins de Oliveira, Maria Glória Vicente, Stela Candioto Melchior, Viviane Cássia Pereira
Cited by: 0

Abstract

This section of the Visa in Debate Journal will present evidence to support post-marketing surveillance of regulated technologies, such as medicines, food, medical devices (equipment, materials for use in health and in vitro diagnostics), results of strategic studies produced in cooperation between the Oswaldo Cruz Foundation Brasília (Fiocruz Brasília) and the National Health Surveillance Agency (Anvisa). This cooperation aims to produce evidence that can support the regulatory decision-making process and, as a teaching and research institution, Fiocruz Brasília has an interest in disseminating the results from the studies. ________________________________________________________________1 PROJETO GEREB-005-FIO-21 “Support for actions for the development of regulation and health surveillance".

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Healthcare Regulation Pharmaceutical Quality and Counterfeiting

Publication details

Journal / source
Vigilância Sanitária em Debate
Pages
1–2
Publication date
4 February 2026
Language
EN